A Clinical Trial to Evaluate the Safety and Efficacy of COM701 in Relapsed Platinum Sensitive Ovarian Cancer

Clinical trial NCT06888921 · RECRUITING

Trial details

NCT number: NCT06888921
Sponsor: Compugen Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Ovarian Cancer Ovarian Cancer Recurrent

Start date: 2025-07-21
Primary completion: 2027-03-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.